Projecis Signs "Top 5" Worldwide Generic Drug Maker and Niche European CRO as Sales Climb for Software Company
SAN DIEGO, Nov. 2, 2012 /PRNewswire/ -- Projecis, Inc., a content and collaboration software company, has recently licensed its flagship platform to a "top 5" worldwide generic drug company and a niche contract research organization (CRO) operating in Central and Eastern Europe, August Research.
The generic drug maker intends to deploy Projecis over the next several months to its staff and use the platform as a centralized project information hub. With the projects they are conducting and the growth they are planning in the U.S. and abroad, Projecis provides a much needed tool to coordinate information among the firm's teams.
August Research, headquartered in Bulgaria, is a CRO that performs Phase I-IV clinical trials throughout Central and Eastern Europe. They are implementing Projecis for clinical projects as well as internal operations.
"Projecis provides a great project team information and collaboration platform," says Dana Niedzielska, CEO of August Research. "With teams working across time zones and countries, special attention is needed to coordinate tasks, updates and information so that project efforts are focused and efficient, and we can achieve the best results possible."
Projecis is currently running pilots at a large pharmaceutical firm and other CROs, as companies embrace the advantages of deploying Projecis for their clinical research programs.
"It's becoming clear that our software is gaining traction in the biopharma industry, with both small and large firms adopting Projecis daily," says Russ Holmes, CEO of Projecis. "Our belief is th